N/A
Completed N=6,915
Trends in Modern Phase 1 Oncology Trials
Source: ClinicalTrials.gov NCT03676270 ↗Enrolled (actual)
6,915
Serious AEs
—
Results posted
Jan 2021
Primary outcomePrimary: Response Rate — 1371 Participants
Summary
Overview of response rate published in recent oncology phase I trials
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Response Rate |
1371 | — |
Eligibility Criteria
Trials based on the following eligibility criteria:
- cancer phase 1 trials
- published from January 1, 2014, through June 30, 2015
Data sourced from ClinicalTrials.gov (NCT03676270). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.